← SynDRA
LEVOCABASTINE
SynDRA canonical compound SYN0025709 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | HRH1 |
|---|
| Mechanism of action | Histamine receptor antagonist |
|---|
| Indication | conjunctivitis |
|---|
| Disease area | ophthalmology |
|---|
All known targets
Mechanisms of action (all sources)
- Histamine receptor antagonist
- HRH1 ANTAGONIST
Drug classes
- Histamine Agents
- Histamine Antagonists
- Histamine H1 Antagonists
- Histamine H1 Antagonists, Non-Sedating
- Neurotransmitter Agents
ATC classes
- R01A · DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
- S01G · DECONGESTANTS AND ANTIALLERGICS
Cross-references
Synonyms
- livostin
- levocabastine hydrochloride
- levophta
- levocabastine HCl
- Levocabastina
- Livostin direct
- Levocabastin
- Levocabastinum
- Livostin
- Levocabastina [Spanish]
- Levocabastinum [Latin]
- Levocabastine (INN)
- Levocabastine [INN:BAN]
- Livostin (TN)
- (3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid
- 1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-4-piperidinecarboxylic acid
- Cabastine
- Cabastine [INN]
- COU3RRH769
- H68BP06S81
- trans-4-Cyano Cabastine
- LEVOCABASTINE [INN]
- Cabastinum
- R 50547
- C26H29FN2O2
- UNII-COU3RRH769
- Levocobastine
- UNII-H68BP06S81
- Prestwick0_001039
- Prestwick1_001039
- Prestwick2_001039
- Prestwick3_001039
- Levocabastine impurity 27
- LEVOCABASTINE [MI]
- SCHEMBL4577
- BSPBio_001257
- LEVOCABASTINE [VANDF]
- SCHEMBL152978
Look up LEVOCABASTINE in the interactive SynDRA portal →